These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 22873679)
1. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679 [TBL] [Abstract][Full Text] [Related]
2. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen. Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651 [TBL] [Abstract][Full Text] [Related]
3. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265 [TBL] [Abstract][Full Text] [Related]
5. The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity. Nakajima T; Sato K; Hanaoka H; Watanabe R; Harada T; Choyke PL; Kobayashi H BMC Cancer; 2014 May; 14():389. PubMed ID: 24885589 [TBL] [Abstract][Full Text] [Related]
6. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765 [TBL] [Abstract][Full Text] [Related]
7. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624 [TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755 [TBL] [Abstract][Full Text] [Related]
9. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723 [TBL] [Abstract][Full Text] [Related]
10. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062 [TBL] [Abstract][Full Text] [Related]
11. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate. Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807 [TBL] [Abstract][Full Text] [Related]
12. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Sato K; Hanaoka H; Watanabe R; Nakajima T; Choyke PL; Kobayashi H Mol Cancer Ther; 2015 Jan; 14(1):141-50. PubMed ID: 25416790 [TBL] [Abstract][Full Text] [Related]
13. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706 [TBL] [Abstract][Full Text] [Related]
14. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate. Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000 [TBL] [Abstract][Full Text] [Related]
15. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903 [TBL] [Abstract][Full Text] [Related]
16. MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy. Nakamura Y; Bernardo M; Nagaya T; Sato K; Harada T; Choyke PL; Kobayashi H Oncotarget; 2016 Mar; 7(13):17254-64. PubMed ID: 26885619 [TBL] [Abstract][Full Text] [Related]
17. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782 [TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy. Sato K; Watanabe R; Hanaoka H; Nakajima T; Choyke PL; Kobayashi H Oncotarget; 2016 Mar; 7(12):14324-35. PubMed ID: 26885688 [TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo. Tang Q; Nagaya T; Liu Y; Lin J; Sato K; Kobayashi H; Chen Y J Control Release; 2017 Aug; 260():154-163. PubMed ID: 28601576 [TBL] [Abstract][Full Text] [Related]
20. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer. Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]